Entries by hayley

Evolution Biotechnologies announces publication of open-access paper on the selection of disease targets for phage therapy

Evolution Biotechnologies (www.evolutionbiotech.com), the UK and US-based company extending the use of biological control into medically important areas, today announced the publication of an invited paper written by Dr. David Harper, its Chief Executive Officer, as part of a special edition of the journal “Viruses”. The special edition is edited by Dr. Harald Brüssow and […]

Evolution Biotechnologies announces positive outcome of international patent search and examination on key patent filing

Bedford, UK, November 14th 2017 ­Evolution Biotechnologies (www.evolutionbiotech.com), the UK and US-based company extending the use of biological control into medically important areas, today announced the highly positive outcome of the international (PCT) stage search and examination of its key patent filing PCT/GB2016/052455, “Acaricides”. The examination, conducted by the European Patent Office (EPO), confirmed the […]

Interview with Dr. David Harper and Dr. Robert Atterbury of Nottingham University.

Bedford, UK, and Austin, Texas; November 14th 2016 Evolution Biotechnologies (www.evolutionbiotech.com), the company working to expand the use of biological control into medically important areas, today announces the release of a video interview with its Chief Officer, Dr. David Harper, conducted by Dr. Robert Atterbury of Nottingham University. The interview forms part of the University’s […]

Dr David Harper presents “Bacteriophage therapy – Still promising but not (yet) delivering” at Euroscicon

Bedford, UK, and Austin, Texas; November 10th 2016 Evolution Biotechnologies (www.evolutionbiotech.com), the company working to expand the use of biological control into medically important areas, today announces a presentation by its Chief Officer, Dr. David Harper. The presentation, entitled “Bacteriophage therapy – Still promising but not (yet) delivering” is to be given on Thursday 10th November […]

Evolution Biotechnologies announces presentation by Chief Officer Dr. David Harper

Bedford, UK, and Austin, Texas; September 14th 2016 ­Evolution Biotechnologies (www.evolutionbiotech.com), the company working to expand the use of biological control into medically important areas, today announces a presentation by its Chief Officer, Dr. David Harper. The presentation, entitled “Bacteriophages as Biological Control Agents” is to be given on Friday 16th September at the conference […]

Evolution Biotechnologies announces that its UK patent application for house dust mites has progressed to the international stage

Evolution Biotechnologies (www.evolutionbiotech.com), the company working to expand the use of biological control into medically important areas, today announced that its UK patent application, “Acaricides” (GB1513981.9), relating to biological controls for house dust mites has progressed to the international stage as PCT application PCT/GB2016/052455. The PCT filing incorporates both data from the previous successful feasibility […]

Evolution Biotechnologies announces expansion into phage therapy

­Evolution Biotechnologies (www.evolutionbiotech.com), the company working to expand the use of biological control into medically important areas, today announced an important development in its operations, with the establishment of its therapeutic division. This will work to develop the therapeutic use of bacteria-killing viruses, or bacteriophages, an approach known as phage therapy. This is recognised as […]

Evolution Biotechnologies announces formation of U.S. subsidiary

Bedford, UK, and Austin, Texas; June 10,  2016 Evolution Biotechnologies (www.evolutionbiotech.com), the company working to expand the use of biological control into medically important areas, today announced the formation of its US-based subsidiary, Evolution Biotechnologies Inc. of Delaware. The company has been established to support operations at the planned company facility in Austin, Texas. Aaron […]

Evolution Biotechnologies announces appointment of Dr. Victor Brugman as senior scientist on its house dust mite control project

Evolution Biotechnologies (www.evolutionbiotech.com), the UK-based company established to expand the use of biological control into medically important areas, today announced the appointment of Dr. Victor Brugman as senior scientist on its dust mite control project. Dr. Brugman will be working with the ARCTEC unit at the London School of Hygiene and Tropical Medicine in London […]

Evolution Biotechnologies announces opening of new corporate facility at Colworth Science Park

Evolution Biotehnologies (www.evolutionbiotech.com), the UK-based company established to expand the use of biological control into medically important areas, today announced the opening of its office at Colworth Science Park in Bedfordshire. This is intended to keystone the development of the company’s laboratory and other facilities at this location over the next year. The office is […]